Clinical Trial Update: Influenza Vaccine To Prevent Adverse Vascular Events:Pilot [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating an influenza vaccine for prevention of adverse vascular events in patients with heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: McMaster University | Conditions: Heart Failure | Phase 4 | Status: COMPLETED